Fracture liaison and osteoporosis medication monitoring program at National Taiwan University Hospital
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area
This program tests whether a coordinated fracture liaison service plus a medication-monitoring service can help people aged 50+ with recent hip or spine fractures or on osteoporosis drugs stick with treatment and get appropriate follow-up.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu) |
| Trial ID | NCT02635022 on ClinicalTrials.gov |
What this trial studies
The program implemented a fracture liaison service (FLS) following the 13 'Capture the Fracture' best-practice standards and a complementary anti-osteoporosis medication (AOM) monitoring service at National Taiwan University Hospital. Eligible participants included patients aged 50 or older with a new hip fracture, newly identified radiographic or clinical vertebral fracture, newly prescribed or recently changed AOMs, or documented poor adherence. Participating physicians referred eligible patients to study coordinators who performed baseline assessments of fracture and osteoporosis risk, documented medical history and AOM use, and provided ongoing medication management and follow-up. The service aimed to close care gaps noted in regional data by improving testing, treatment initiation, and adherence over time.
Who should consider this trial
Good fit: People aged 50 or older with a new hip fracture, newly identified vertebral fracture, newly prescribed or changed anti-osteoporosis medication, poor adherence to AOMs, or whom clinicians believe would benefit from coordinated osteoporosis and medication management.
Not a fit: Patients with life expectancy under two years, atypical fractures, major communication barriers, participation in other medication trials, or who refuse assessments are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could increase osteoporosis testing and medication adherence and lower the risk of subsequent fractures.
How similar studies have performed: Other fracture liaison services that follow the Capture the Fracture standards have improved rates of bone density testing and osteoporosis treatment in multiple settings, though results on long-term fracture reduction are variable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>=50 and one of the below * New hip fracture in orthopedic ward * Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics * Newly prescribed with AOMs * Recent change of AOMs * Poor adherence to AOMs * Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements. Exclusion Criteria: * Life expectancy less than 2 years or can't be assessed for communication problems * Atypical fractures * Patient in other medication clinical trials * Unwilling to accept the assessment and treatment
Where this trial is running
Hsinchu
- National Taiwan University Hospital, Chutung branch — Hsinchu, Taiwan (Recruiting)
Study contacts
- Principal investigator: Ding-Cheng Chan, MD, PhD — National Taiwan University Hospital, Chutung branch
- Study coordinator: Ding-Cheng Chan, MD, PhD
- Email: doctord6226@yahoo.com
- Phone: 886-2-23123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.